Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE)
about
Silver Nanoforms as a Therapeutic Agent for Killing Escherichia coli and Certain ESKAPE PathogensA longitudinal assessment of antimicrobial susceptibility among important pathogens collected as part of the Tigecycline Evaluation and Surveillance Trial (T.E.S.T.) in France between 2004 and 2012.Dynamic changes of microbial flora and therapeutic consequences in persistent peritonitis.Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.Characterization of fecal extended-spectrum-β-lactamase-producing Escherichia coli in a remote community during a long time period.Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.An outbreak of caprine meningoencephalitis due to Escherichia coli O157:H7.Vancomycin-resistant vanB-type Enterococcus faecium isolates expressing varying levels of vancomycin resistance and being highly prevalent among neonatal patients in a single ICUEfficiency of different control measures for preventing carbapenemase-producing enterobacteria and glycopeptide-resistant Enterococcus faecium outbreaks: a 6-year prospective study in a French multihospital institution, January 2010 to December 2015Hospital statistics for antibiotics: defined versus prescribed daily dose
P2860
Q28828359-6499DE1F-4070-46D2-86F4-DE8DC05D6120Q35067853-C94FD585-BA27-4BD0-96D9-7FAA6ABA8D1AQ35162610-046BA630-9C6D-489A-872C-8656ACE374AFQ36526872-C9F7D3A6-F3DE-4E5A-8225-BA460E7FCAE9Q37263825-8769BFFF-DAD4-4664-B920-E064E1EF2E9BQ41693355-1F51D87B-1665-4E02-B9B0-0BE4BD51DAF8Q42243170-ED9CE887-F8A3-464D-A2F0-54CBD8313D9AQ42459893-535881ED-3FD7-4BD1-91A2-9E8237D6570CQ52682677-571326CB-6984-4D45-837B-B43ACE3C27DFQ56972688-BA44C900-0569-4B19-AD9D-960B6E550268
P2860
Twenty years of antimicrobial resistance control programme in a regional multi hospital institution, with focus on emerging bacteria (VRE and CPE)
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Twenty years of antimicrobial ...... merging bacteria (VRE and CPE)
@en
Twenty years of antimicrobial ...... erging bacteria (VRE and CPE).
@nl
type
label
Twenty years of antimicrobial ...... merging bacteria (VRE and CPE)
@en
Twenty years of antimicrobial ...... erging bacteria (VRE and CPE).
@nl
prefLabel
Twenty years of antimicrobial ...... merging bacteria (VRE and CPE)
@en
Twenty years of antimicrobial ...... erging bacteria (VRE and CPE).
@nl
P2860
P356
P1476
Twenty years of antimicrobial ...... merging bacteria (VRE and CPE)
@en
P2093
Sandra Fournier
Vincent Jarlier
P2860
P2888
P356
10.1186/2047-2994-1-9
P577
2012-02-13T00:00:00Z
P5875
P6179
1014792848